Integer Holdings (ITGR) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jul 03 2026 to Jun 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Integer Holdings Corporation  (NYSE: ITGR)

Integer Holdings's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Integer Holdings in the second quarter 2026?
Integer Holdings Corporation achieved a return on average equity (ROE) of 7.43 % in its second quarter 2026, this is above ITGR's average return on equity of 5.72%.
Integer Holdings Corporation shareholder's equity over the 12 months ending in its second quarter 2026 are valued at $1,727 million

ROE fell compared to the first quarter 2026, despite the net income growth of 43.01% from the first quarter 2026.

Within the Medical Equipment & Supplies industry 48 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the first quarter 2026 from 1524 to 1647.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jul 03 2026)
II. Quarter		 (Apr 03 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 26 2025)
III. Quarter		 (Jun 27 2025)
II. Quarter
Y / Y Equity Change 0.89 % 5.61 % 7.87 % 7.69 % -
Y / Y Net Income Change -36.22 % - 48.63 % 11.96 % 18.44 %
Net Income (TTM) in Millions 128 142 103 87 83
Return On Equity (TTM) 7.43 % 8.23 % 6.05 % 5.21 % 5.05 %
ITGR's Total Ranking # 1647 # 1524 # 1372 # 786 # 1669
Equity (TTM) in Millions 1,719 1,697 1,747 1,746 1,704
Seq. Equity Change 1.29 % -2.85 % 0.05 % 2.48 % 6.03 %
Seq. Net Income Change 43.01 % -66.04 % 22.51 % 7.21 % -

Back to ITGR Management Effectiveness >> ITGR's 5 Years Annual ROE >> Compare ITGR ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 49
Sector # 159
Overall # 1647

Return On Equity Statistics
High Average Low
12.42 %
5.72 %
-5.19 %
(Jun 29 2018)   (Jul 01 2016)





ITGR Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 1,747 1,619 1,519 1,417 1,355
Y / Y Equity Change 7.87 % 6.59 % 7.17 % 4.63 % 6.58 %
Net Income in Millions 103 120 91 66 97
Y / Y Net Income Change -14.25 % 32.26 % 36.57 % -31.43 % 25.3 %
Return On Equity 5.89 % 7.4 % 5.97 % 4.68 % 7.15 %

Back to ITGR Management Effectiveness >> ITGR's 5 Years Annual ROE >> Compare ITGR ROE to its Competitors




Annual Roe Comment
In 2025 ROE decreased compared to the previous year to 5.89 %, due to deterioration of net income.


More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ITGR's' Return on Equity at Yahoo Finance
ITGR's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ITGR's Competitors
Subscribers only: Roe for Integer Holdings's Suppliers
Subscribers only: Return On Equity for ITGR's Customers




Companies with similar Return On Equity at Jul 03 2026, within Healthcare Sector ROE
United Therapeutics Corporation  20.18 %
Ligand Pharmaceuticals Incorporated  20.06 %
Harmony Biosciences Holdings inc   20.06 %
Pediatrix Medical Group Inc   19.89 %
Theravance Biopharma inc   19.40 %
Krystal Biotech Inc   19.34 %
Ani Pharmaceuticals Inc  19.33 %
Brightspring Health Services Inc   18.93 %
Sbc Medical Group Holdings Incorporated  18.69 %
West Pharmaceutical Services Inc   18.51 %
Intuitive Surgical Inc   17.82 %
Standard Biotools Inc   17.64 %
Inspire Medical Systems inc   17.62 %
Medinotec Inc   17.47 %
Lemaitre Vascular Inc   16.93 %
Ufp Technologies Inc   16.72 %
Ensign Group Inc  16.53 %
Stryker Corp  16.36 %
Nephros Inc   16.20 %
Spero Therapeutics Inc   16.17 %
Progyny Inc   15.98 %
Collegium Pharmaceutical Inc   15.96 %
Alpha Pro Tech Ltd   15.43 %
Livanova Plc  15.41 %
Biolife Solutions Inc   15.28 %
Lifevantage Corp  15.06 %
Quest Diagnostics Inc  14.85 %
Infusystem Holdings Inc  14.81 %
Boston Scientific Corporation  14.77 %
Strata Critical Medical Inc   14.27 %

Date modified: 2026-09-12T06:15:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.